Payer LCD policy requires a specific anemia code and a documented hemoglobin below 10 g/dL for ESA claims
Book a Consultation How It Works 5-Amino-1MQ works by inhibiting the NNMT enzyme, supporting NAD+ metabolism and cellular energy production through a targeted biochemical pathway
83 Ide, H

Key selective action features: No Growth Hormone Receptor Binding: Does not activate GH receptors responsible for IGF-1 stimulation and systemic growth effects Preserved Glucose Metabolism: No impact on blood sugar regulation, insulin sensitivity, or diabetic risk markers No Tissue Growth Effects: Does not promote muscle hypertrophy, organ growth, or cell proliferation pathways Adipose-Specific Targeting: Works primarily through beta-3 adrenergic receptors concentrated in fat tissue No IGF-1 Elevation: Clinical trials confirmed no changes in serum IGF-1 levels at therapeutic doses Isolated Lipolytic Action: Maintains the fat-breaking properties of growth hormone fragment 176-191 without broader effects Selective Mechanism: Structural differences from full-length GH prevent binding to receptors mediating non-fat-related effects Clinical Validation: Human studies in 900+ participants confirmed selective fat metabolism without systemic hormonal changes The following guide provides detailed analysis of AOD-9604 s selective action and why this selectivity matters for safe, targeted fat metabolism

Our medical staff evaluates your symptoms, allergies, medications, and medical history to ensure you receive the best treatment for your needs
-Amanda Yep hCGer 11: I used the Lipo shots while on HCG and continued on them through maintenance